On the road to an impact factor for eCAM

Evidence-based Complementary and Alternative Medicine

Volumn 4, Issue 1, 2007, Pages 1-2

  Cooper, Edwin L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ALTERNATIVE MEDICINE; EDITORIAL; ESTHETICS; EVIDENCE BASED MEDICINE; HEALING; MEDICAL LITERATURE; PRIORITY JOURNAL; PUBLICATION;

EID: 33947177121     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1093/ecam/nem006     Document Type: Editorial

References (7)

1. Cooper EL. Regional strength in CAM. Evid-Based Complement Alternat Med 2006;3:291-2.
2. Müller WEG, Schröder HC, Weins M, Perovic-Ottstadt S, Batel R, Müller I. Traditional and modern biomedical prospecting: Part II - The benefits: approaches for a sustainable exploitation of biodiversity (secondary metabolites and biomaterials from sponges). Evid-Based Comeplement Alternat Med 2004;1:133-44.
3. Cooper EL. Commentary on traditional and modern biomedical prospecting: Part II - the benefits by Werner E.G. Müller, Heinz C. Schröder, Matthias Wiens, Sanja Perovic-Osstadt, Renato Batel and Isabel M. Müller: Anti-protozoa and antiviral activities of noncytotoxic truncated and variant analogues of mussel defensin by P. Roch, A. Beschin and E. Bernard. Evid-Based Complement Alternat Med 2004;1:133-44.
4. Cooper EL. Drug discovery, CAM and natural products. Evid-Based Complement Alternat Med 2004;1:215-7.
5. Cooper EL. Bioprospecting: a CAM frontier. Evid-Based Complement Alternat Med 2005;2:1-3.
6. Cooper EL. CAM, eCAM, bioprospecting: the 21st century pyramid. Evid-Based Complement Alternat Med 2005;2:125-7.
7. Nigam Y, Bexfield A, Thomas S, Ratcliffe NA. Maggot therapy: the science and implication of CAM Part II - Magots combat infection. Evid-Based Complement Alternat Med 2006;3:303-8.